FDS 135.77 Factset Research Systems Inc $FDS Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
FDS 135.77 Factset Research Systems Inc $FDS Hit a 52 week high of 136.23 Currently at 135.77 -0.31 -0.23% With a day low of 135.74 and a total volume of 5,949.

FDS Factset Research Systems Inc Recent Headline News

Geographic Revenue Exposure Data Now Available in FactSet Portfolio Analytics
GlobeNewswire - Thu Nov 06, 9:30AM CST
FactSet Research Systems Inc. (NYSE:FDS) (Nasdaq:FDS), a leading provider of financial information and analytical applications to the global investment community, today announced the release of the FactSet Geographic Revenue Exposure (GeoRevs) data within the FactSet Portfolio Analytics product to give investors a better way to uncover risk and fine-tune exposures.
FDS: 135.95 (-0.13)

Insider Trading Alert - FDS, BGS And MSI Traded By Insiders
at The Street - Wed Nov 05, 10:24AM CST
Stocks with insider trader activity include FDS, BGS and MSI
MSI: 63.85 (-0.09), BGS: 29.04 (-0.56), FDS: 135.95 (-0.13)

McGraw Hill Q3 Earnings Beat, Revenues Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 10:52AM CDT
McGraw Hill Financial, Inc's (MHFI) third-quarter 2014 adjusted earnings of $1.02 per share beat the Zacks Consensus Estimate but revenues of $1,263 million failed to meet expectations.
DNB: 123.80 (-0.48), MHFI: 89.93 (-0.67), FDS: 135.95 (-0.13), MCO: 99.46 (+0.14)

Stock Market News for October 21, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 9:10AM CDT
Dismal earnings result from IBM offset benchmarks’ gains yesterday, which nonetheless finished in the green
DHI: 23.61 (+0.18), QEPM: 15.41 (+0.03), HAS: 56.61 (-0.47), LEN: 46.31 (+1.02), QEP: 24.46 (-0.32), TSO: 71.74 (+0.31), IBM: 163.65 (+0.16), GCI: 30.59 (-0.17), PHM: 20.68 (+0.37), HAL: 52.68 (-0.95), TLLP: 57.05 (-0.51), TOL: 33.32 (+0.37), FDS: 135.95 (-0.13)

Shareholders Turn Their Attention to Golden Parachutes and Political Contributions While More Companies Implement Winning Governance Proposals, The Conference Board Reports
PR Newswire - Thu Sep 18, 9:00AM CDT
Research released today by The Conference Board in collaboration with FactSet reconstructs how shareholder activism and voting at annual general meetings (AGMs) of U.S. public companies have evolved in the last five years. The report, Proxy Voting Analytics (2010-2014), examines data from more than 2,500 AGMs held at Russell 3000 companies between January 1 and June 30. It shows a fundamental shift in the types of resolutions submitted to a vote by shareholders, the sophistication developed by activist investors in the use of technology and social media to agitate for corporate change outside of the AGM, and the increased propensity of senior management to implement precatory shareholder proposals on corporate governance that have received the support of a majority of voting shares.
FDS: 135.95 (-0.13)

Why FactSet (FDS) Stock Is Down Today
at The Street - Wed Sep 17, 10:37AM CDT
Shares of FactSet Research Systems (FDS) are falling after Piper Jaffray (PJC) downgraded the company to 'neutral' from 'overweight' with a price target of $130.
FDS: 135.95 (-0.13)

Shares of FDS Up 9.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Sep 17, 9:55AM CDT
SmarTrend identified an Uptrend for Factset Research Systems (NYSE:FDS) on March 18th, 2014 at $112.51. In approximately 6 months, Factset Research Systems has returned 9.89% as of today's recent price of $123.64.
FDS: 135.95 (-0.13)

Company News for September 17, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Wed Sep 17, 9:10AM CDT
Companies in the News are: GRT,ALOG,DKS,FDS
DKS: 46.07 (-0.40), ALOG: 72.68 (-0.26), GRT: 13.90 (-0.01), FDS: 135.95 (-0.13)

FactSet Research Systems (FDS) Is Today's Water-Logged And Getting Wetter Stock
at The Street - Wed Sep 17, 9:00AM CDT
Trade-Ideas LLC identified FactSet Research Systems (FDS) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
FDS: 135.95 (-0.13)

FactSet Q4 Earnings In Line, Revenues Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 17, 8:10AM CDT
FactSet Research Systems Inc. (FDS) reported fourth-quarter fiscal 2014 earnings per share of $1.31, which came in line with the Zacks Consensus Estimate.
MU: 33.20 (+0.11), MSCI: 48.30 (+0.22), EFX: 78.48 (+0.22), FDS: 135.95 (-0.13)

Downgrade Alert for Factset Research Systems (FDS)
Comtex SmarTrend(R) - Wed Sep 17, 6:54AM CDT
Factset Research Systems (NYSE:FDS) was downgraded from Overweight to Neutral at Piper Jaffray today. The stock closed yesterday at $126.76 on volume of 582,000 shares, above average daily volume of 246,000. In the past 52 weeks, shares of Factset Research Systems have traded between a low of $101.41 and a high of $129.75 and closed yesterday at $126.76, which is 25% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has advanced 0.3%.
FDS: 135.95 (-0.13)

FactSet beats Q4 EPS views
at Investor's Business Daily - Tue Sep 16, 5:49PM CDT
Per-share earnings of the financial information service company grew 11% to $1.31 in Q4, topping Thomson Reuters' views by a penny. Revenue rose 9% to $238.7 mil, beating forecasts for $236.9 mil. FactSet (FDS) expects Q1 '15 revenue of $240 mil-$243...
FDS: 135.95 (-0.13)

FactSet Q4 EPS, Revenue Beat Street, But Shares Down
at Investor's Business Daily - Tue Sep 16, 12:00PM CDT
The financial information service FactSet reported fourth-quarter earnings and revenue results that even its rival says edged past Wall Street expectations. FactSet (FDS) earned $1.31 a share on an adjusted basis, an 11% rise from the prior-year...
TRI: 37.91 (-0.05), FDS: 135.95 (-0.13)

FactSet Sets Itself Up For a Good Year
Alex Dumortier, CFA, The Motley Fool - Motley Fool - Tue Sep 16, 10:20AM CDT
Financial data and software provider FactSet Research Systems announced its fiscal fourth quarter results this morning. There are no major surprises and that's rather a good thing – a reflection of its high-quality, "steady-as-she-goes" business...
FDS: 135.95 (-0.13)

Will FactSet Research Systems (FDS) Stock Be Helped By This Earnings Beat?
at The Street - Tue Sep 16, 10:10AM CDT
FactSet Research Systems (FDS) shares are down despite matching and beating analysts earnings and revenue expectations.
FDS: 135.95 (-0.13)

FactSet Research Systems Reports Results for the Fourth Quarter of Fiscal 2014
GlobeNewswire - Tue Sep 16, 6:00AM CDT
-- ASV increased $31.6 million, up 7.3% organically
FDS: 135.95 (-0.13)

Will FactSet Research (FDS) Beat Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 8:30AM CDT
FactSet Research Systems Inc. (FDS) is set to report fiscal fourth-quarter 2014 results on Sep 16, 2014.
MU: 33.20 (+0.11), MSCI: 48.30 (+0.22), BBRY: 11.21 (+0.12), FDS: 135.95 (-0.13)

ADBE, FDS and APOG Earnings Reports Potentially Impacted by Research Linking Stock Price and HR Metrics
M2 - Mon Sep 15, 3:54AM CDT
September 16, 2014 - The Human Capital Management Institute (HCMI), an industry leader in predictive human capital management metrics and advanced workforce analytics solutions, released research showing that profit and revenue don't actually predict stock price, but some other, little-used metrics do (http://hcminst.com/linking-human-capital-to-business-performance). The study, performed by Jeff Higgins, CEO of the Human Capital Management Institute, and Pepperdine University professor Donald Atwater, shows that human capital contributions to stock performance are clearly linked. According to the model, a 10% increase in human capital productivity metrics are associated with stock price gains of -.7% to 29% by sector. Human capital metrics are significant in all sectors explaining 35% to 64% of rate of change in stock prices, far more than the average 1% explained by net income.
APOG: 44.43 (+0.01), ADBE: 71.87 (+0.17), FDS: 135.95 (-0.13)

Stocks Fall On Interest Rate Worries, But Yahoo Jumps
at Investor's Business Daily - Fri Sep 12, 3:25PM CDT
Stocks fell Friday, with the S&P 500 snapping a five-week winning streak, after a strong retail sales report spurred fears of an early interest rate hike. The S&P 500 lost 0.6% and the Nasdaq 0.5%, while the Dow Jones industrial average slid 0.4%....
FDX: 172.24 (+0.50), YHOO: 48.40 (-1.01), RHT: 61.44 (+0.03), XOM: 96.00 (-0.28), GIS: 51.13 (+0.26), FDS: 135.95 (-0.13), NE: 21.03 (-0.12)

Shares of FDS Up 13.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Sep 10, 9:28AM CDT
SmarTrend identified an Uptrend for Factset Research Systems (NYSE:FDS) on March 18th, 2014 at $112.51. In approximately 6 months, Factset Research Systems has returned 12.99% as of today's recent price of $127.13.
FDS: 135.95 (-0.13)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 304

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Sintilimab Poised for New Milestone in Melanoma Fight

Updated Category News Views 39

An Opening Shot: NMPA's Decision Window Well, here's the latest chapter in the saga of battling advanced melanoma with some real gritty numbers behind it. Innovent Biologics has thrown its hat back in the ring with news that the China National Medical Products Administration (NMPA) has embraced a new indication application for their drug sintilimab. They're teaming it up...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 421

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 212

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
HCLTech Partners with Rapidus on Semiconductor Future

Updated Category News Views 0

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 264

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 177

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 264

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Dar Global Eyes Dubai for Strategic Real Estate Moves

Updated Category News Views 0

Tapping into Dubai's Real Estate Allure Every seasoned investor knows the real estate game ain't for the faint of heart, especially when you’re playing in a market as competitive as Dubai's. But here comes Dar Global Capital Partners (DGCP), throwing their hat into the ring with a fresh strategy centered around high-value real estate. Sure, they aren't new to the...

Continue Reading

Top 5 Most Recently Viewed Articles

Dandy® Celery Innovates Back-to-School Snacking Options

Updated Category News Views 53

Dandy® Celery Offers Innovative Snacking for Back-to-School Dandy® Produce, a leading name in fresh celery, is here to support families as they navigate back-to-school routines. They provide a variety of quick and healthy meal and snack options. Their fresh-cut celery sticks are a perfect addition to school lunches, afterschool snacks, and even quick sides for busy...

Continue Reading
General Dynamics (GD): Navigating Aerospace Headwinds and Opportunities

Updated Category News Views 209

General Dynamics: Current Market Dynamics General Dynamics Corporation (NYSE: GD) is widely recognized for its pivotal role in the aerospace and defense sectors. The company has a strong reputation, particularly for producing Gulfstream jets, alongside its diverse range of military and marine systems. Despite its established position, General Dynamics has been...

Continue Reading
SunCar Technology Group Inc. Enters NASDAQ Golden Dragon Index

Updated Category News Views 74

SunCar Technology Group Inc. Achieves Milestone Inclusion SunCar Technology Group Inc. (NASDAQ: SDA), a prominent player in the cloud-based B2B automotive services and insurance sector, proudly announces its recent addition to the NASDAQ Golden Dragon China Index. This significant achievement illustrates the company's upward journey and strengthens its market positioning....

Continue Reading
Strategic Investment by BrainsWay to Enhance Mental Health Solutions

Updated Category News Views 165

BrainsWay's Expansion Plans and Strategic Investment This investment marks BrainsWay’s entrance into the market for mental health therapies that can be administered outside of a clinic, including at home. Neurolief’s breakthrough Proliv™Rx device is pending Premarket Approval from the U.S. FDA, and if granted, it will set a precedent as the first FDA-cleared medical...

Continue Reading
Future Projections: Cosmetic Surgery Market Growth Insights

Updated Category News Views 97

The Expanding Cosmetic Surgery Market The cosmetic surgery market is anticipated to experience significant growth over the coming years, with projections indicating an increase from USD 56.98 billion in 2024 to approximately USD 83.34 billion by 2034. This impressive growth represents a compound annual growth rate (CAGR) of 3.84% from 2024 to 2034, driven by a variety of...

Continue Reading